摘要
Charlotte VAN DEN BERG 医师
皮肤科医师, (住院医师)
The Diluent Dilemma: Investigating Hypersensitivity in Bacteriostatic Botulinum Toxin Preparations
目标: To highlight benzyl alcohol hypersensitivity as a rare but relevant complication of BoNT-A procedures.
介绍: Botulinum toxin type A (BoNT-A) is widely used in aesthetic and therapeutic medicine. Although the FDA recommends preservative-free saline for reconstitution, many clinicians use bacteriostatic saline containing benzyl alcohol to reduce injection discomfort. Benzyl alcohol, however, is a known allergen capable of triggering immediate hypersensitivity reactions. Awareness of this potential risk is crucial for safe and individualized BoNT-A practice.
材料 / 方法: A 37-year-old woman developed facial urticaria and angioedema shortly after onabotulinumtoxinA injections reconstituted with bacteriostatic saline containing benzyl alcohol. A reproducible reaction occurred following a 0.05 mL intradermal test dose, confirming hypersensitivity. Negative patch and prick tests were considered false negatives due to insufficient allergen concentration and limited dermal penetration.
结果: Following the intradermal test, identical urticarial plaques and angioedema developed within 15 minutes, confirming immediate hypersensitivity to benzyl alcohol rather than to botulinum toxin itself. Symptoms resolved completely within 72 hours after a short course of systemic corticosteroids. No further reactions occurred when reconstituted with preservative-free saline.
总结: Bacteriostatic saline, though commonly used for BoNT-A reconstitution, may provoke immediate hypersensitivity due to benzyl alcohol. Even with negative patch tests, clinicians should suspect this diluent in cases of post-injection urticaria or angioedema. Switching to preservative-free saline is recommended to prevent recurrence and ensure patient safety.
披露 - Charlotte VAN DEN BERG
> 您是否获得了任何资金来支持您关于这个主题的研究?
不是
> 您在这项研究工作中是否获得过任何酬金、报酬或其他形式的补偿?
不是
> 您是否与任何可能与您研究中涉及的药物、材料或器械存在激烈竞争的实体有任何财务关系?
不是
> 您是否拥有或已申请过与您研究中所讨论的仪器、药物或材料相关的任何专利?
不是
这项工作没有任何直接或间接的资金支持。由作者自己承担责任。